No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
AVDL240816P12500
- 0.13
- -0.06-31.58%
15min DelayClose Jul 22 16:00 ET
0.15High0.12Low
0.15Open0.19Pre Close7 Volume411 Open Interest12.50Strike Price88.00Turnover80.20%IV24.89%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.13Extrinsic Value100Contract SizeAmericanOptions Type-0.0746Delta0.0410Gamma131.76Leverage Ratio-0.0096Theta-0.0008Rho-9.83Eff Leverage0.0060Vega
Intraday
- 5D
- Daily
News
Avadel Pharmaceuticals Plc's (NASDAQ:AVDL) Path To Profitability
Oppenheimer's Top SMID Ideas Within High-growth Themes
Avadel Pharmaceuticals to Join Russell 3000 Index
Oppenheimer Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Maintains Target Price $29
Rodman & Renshaw Initiates Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Announces Target Price $27
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
Comments
The recent sale from a key insider at the current share price of US$14.12 raises concerns, despite insiders holding sizable shares in the company. This trend combined with limited recent insider buying causes a cautious outlook towards the company's stock.
$Avadel Pharmaceuticals(AVDL.US$
helloooooo dippy. should run rest of day. 👍🏻
Enjoy your Veterans day and have a blessed weekend.
helloooooo dippy. should run rest of day. 👍🏻
Enjoy your Veterans day and have a blessed weekend.
1
Insider sales surpassed insider buying at Avadel Pharmaceuticals in recent months, but yearly transactions are positive. Insider ownership aligns with shareholders, with recent sales not raising major concerns.
1
1
Read more